Oncolytics Biotech Inc. (ONCY) Social Stream

Oncolytics Biotech Inc. (ONCY): $2.27

0.00 (0.00%)

POWR Rating

Component Grades













Add ONCY to Watchlist
Sign Up

Industry: Biotech


of 499

in industry

Featured Post From StockTwits About ONCY

$ONCY we will a see a huge spike, when Onc announces some $$$ partnership.
being phase 3 MBc , Car-t , or some other yet undefined.
could even be the G.I. Cancer
Or a complete buy- out offer.
Or the next short squeeze , expectations etc.
some extremely positive results out of any of the on going trials.
There are a lot of reasons , for ONC to be much higher & should be much higher.
My $$ is betting before end of this year. Longest, Q1 of 2022.
so 1- 8 months.
They have ample $$ to last end of 2022.
The regulations indicate, they must have 12 months of operating $, to stay listed.
meaning they will need to go back to the ATM by end of this year, Q1, of next.
previous fireside chats, Matt indicated , “ not likely to be needed as we expect other business before then”.
Canadafan14, published July 29, 2021

What Else are ONCY Traders Talking About?

Other tickers frequently mentioned alongside ONCY is .

Other Notable StockTweets About ONCY

$ONCY Coffee has done such a great job of instilling confidence with the investing community of how the Oncolytic virus in going to be the next great er ah um ah well ahem, oh well “ I still get my 2 grand a day 7 days a week regardless and just trust me because look how rich I’ve become oops I mean all the progress ooops um er ah I have to confer with Cannacord before I do anything because they are paying my wages oops I mean you suckers oops shareholders are but um I would buy some shares but why should I when if I keep my mouth shut I can get massive of amount of cheap options and put my 2 grand a day away and charge everything I do every day to the company account even though I go MIA. For months at a time ! What a great job I have!”

scamman, published July 23, 2021

$ONCY As I have been saying for some time now, $ONCY is clearly oversold - the stock price is riding the lower Bollinger well below the 200SMA and most known support levels with no basis/news to justify the move, aside from the broader macroeconomic concerns affecting most of the small biotech sector. I was looking at $2.21 from Dec-2020 as a possible point for reversal - I have been dollar cost averaging since the RSI went sub-terranean, and plan to continue adding on further declines. The stock price is reaching a point now (IMO) where there is 50% short-term upside back into its consolidation pattern. $ONCY presented at the Ladenburg Thalmann Healthcare Conference this week, which only adds the interest/eyes on the Company. Again-I see $ONCY as a longer-term play; however, this is a unique oversold position on which I have been adding now in earnest.

BinaryLogic, published July 16, 2021

Loading social stream, please wait...

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 2.0972 seconds.